Saakshi Medtech and Panels Limited — Disclosure of material issue

Saakshi Medtech and Panels Limited has informed stock exchanges that it has received In-Principle Approval from the National Stock Exchange (NSE) for a proposed preferential issue of shares. This means the company has cleared the initial regulatory hurdles and is now authorized to proceed with issuing new equity to select investors, subject to final approvals.

For investors, this development is significant as a preferential issue is a method of raising capital by selling shares to specific investors, often at a discount. This move suggests the company is looking to bolster its financial position or fund expansion plans. It can dilute the ownership percentage of existing shareholders if the new shares are issued on a fully diluted basis.

Investors should monitor the company's future announcements for details on the price and the purpose of the funds raised. It is also important to check if the preferential issue is being done at a premium or a discount to the current market price, as this will impact the valuation of the stock.